Search

everythinglearnresearchcommunity

for

Search:↓

Men with shaved heads are seen as more dominant but older and less attractive.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

The new Follicular Map method could help assess hair treatment effectiveness but has some limitations.

Finasteride treats hair loss but may affect prostate cancer detection.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

Minoxidil and spironolactone slow hair loss in women.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

Untreated androgenetic alopecia leads to progressive hair loss in men.

The document concludes that careful planning, efficient use of every hair graft, and setting surgical priorities are crucial for successful hair restoration surgery.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Hair loss affects self-esteem and quality of life; treatments can help.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

AXR3 and SHY2 genes control the growth and timing of root hair development in plants.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

MicroRNA-214 is important for skin and hair growth because it affects the Wnt pathway.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.